Today, Healthcare Business Insights www.hbinsights.com (HBI), a part of Decision Resources Group www.decisionresourcesgroup.com (DRG), announced...
A Cost-Utility Analysis Of Vertex's CF Drugs — What It Teaches Us About Trial Design
Lessons In Navigating The Increasingly Complex World Of Orphan Drug Commercialization
Spark's Luxturna Gene Therapy: What Can We Learn From Its Development & Commercialization?
Clover Health is laying off a quarter of its workforce, two months after $500M fundraise
